DIMO Healthcare, a leader in the Sri Lankan healthcare sector, has introduced the country’s first Echosens FibroScan® Expert ...

Echosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in MASH diagnosis and care.

This expansion will change the trajectory of MASH by focusing on early detection, diagnosis, and access to care.

By combining their diagnostic and therapeutic expertise, Echosens and Boehringer Ingelheim aim to help close persistent gaps ...

As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of ...

DIMO Healthcare has introduced the country’s first Echosens FibroScan Expert 630, revolutionizing non-invasive liver ...

DIMO Healthcare, a leader in the Sri Lankan healthcare sector, has introduced the country’s first Echosens FibroScan® Expert 630, revolutionizing non-invasive liver assessments. This innovative ...

The agency managing the federal government’s health IT efforts has a new leader, a spokesperson for the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT ...

The White House released a more detailed budget proposal on Friday that yields more information on how the Trump administration is aiming to reshape the HHS next year, including drastic cuts to ...

Khindivi is approved as a replacement therapy for children aged five years and above with adrenocortical insufficiency. Credit: Caleb Woods on Unsplash. Eton Pharmaceuticals’ new drug application (NDA ...

Advisers to the Food and Drug Administration have recommended COVID-19 vaccine makers continue to target their shots to the so-called JN.1 coronavirus strain for the upcoming fall and winter seasons, ...